Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study

被引:11
|
作者
Giunta, Alessandro [1 ]
Babino, Graziella [1 ]
Ruzzetti, Manuela [1 ]
Manetta, Sara [1 ]
Chimenti, Sergio [1 ]
Esposito, Maria [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Dermatol, Viale Oxford 81, I-00133 Rome, Italy
关键词
Anti-tumor necrosis factor-; body mass index; body weight; etanercept; obesity; psoriasis; THERAPY;
D O I
10.1177/0300060515593254
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim To investigate the role of body mass index (BMI) and weight in the long-term efficacy of etanercept in patients with psoriasis. Methods Medical records were retrospectively analysed. Extracted data included weight, BMI, comorbidities and psoriasis area severity index (PASI). Patients were stratified by weight (<80kg or 80kg) and BMI (healthy, BMI 22 - 24.99kg/m(2); overweight, BMI 25 - 29.99kg/m(2); obese, BMI 30kg/m(2)). Results The study included 66 patients. Body weight had no effect on etanercept efficacy. There was a significant reduction in etanercept efficacy in obese patients (n=12) compared with healthy weight (n=33) or overweight (n=21) patients. Conclusion Obesity has a negative effect on the efficacy of etanercept in psoriasis.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 50 条
  • [1] INFLUENCE AND VARIATION OF THE BODY MASS INDEX IN PATIENTS TREATED WITH ETANERCEPT FOR PLAQUE-TYPE PSORIASIS
    Esposito, M.
    Mazzotta, A.
    Saraceno, R.
    Schipani, C.
    Chimenti, S.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (01) : 219 - 225
  • [2] A Retrospective Study of Patients with Psoriasis Treated with Biologics: Relation to Body Mass Index and Gender
    Salah, Louai A.
    Gillstedt, Martin
    Osmancevic, Amra
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (07) : 974 - 975
  • [3] Psoriasis and body mass index
    Hercogova, Jana
    Ricceri, Frederica
    Tripo, Lara
    Lotti, Torello
    Prignano, Francesca
    DERMATOLOGIC THERAPY, 2010, 23 (02) : 152 - 154
  • [4] Obesity and psoriasis: body weight and body mass index influence the response to biological treatment
    Puig, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (09) : 1007 - 1011
  • [5] The influence of body weight of patients with chronic plaque psoriasis on biological treatment response
    Kisielnicka, Anna
    Szczerkowska-Dobosz, Aneta
    Nowicki, Roman J.
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (02): : 168 - 173
  • [6] Change in body weight and body mass index in psoriasis patients receiving biologics: A systematic review and network meta-analysis
    Wu, Ming-Ying
    Yu, Chia-Ling
    Yang, Shih-Jyun
    Chi, Ching-Chi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (01) : 101 - 109
  • [7] Risk of psoriasis according to body mass index: A retrospective cohort analysis
    Norden, Alexandra
    Rekhtman, Sergey
    Strunk, Andrew
    Garg, Amit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (05) : 1020 - 1026
  • [8] Body mass index in psoriatic patients with or without familial psoriasis
    Bayaraa, Bolortuya
    Arima, Hisatomi
    Imafuku, Shinichi
    JOURNAL OF DERMATOLOGY, 2020, 47 (04) : 402 - 404
  • [9] Body Mass Index Influence for the Personalization of the Monoclonal Antibodies Therapy for Psoriasis
    Anghel, Flavia
    Nitusca, Diana
    Cristodor, Patricia
    LIFE-BASEL, 2021, 11 (12):
  • [10] Associations between body mass index and severity of psoriasis
    Sobhan, Mohammadreza
    Farshchian, Mahmoud
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2017, 10 : 493 - 498